Search

Subject MDS/MPN -- HMA -- genomics -- response -- survival

1. Genomic landscape of myelodysplastic/myeloproliferative neoplasm can predict response to hypomethylating agent therapy. Issue 8 (3rd July 2022)

Authors:
Karantanos, Theodoros; Tsai, Hua-Ling; Gondek, Lukasz P.; DeZern, Amy E.; Ghiaur, Gabriel; Dalton, W. Brian; Gojo, Ivana; Prince, Gabrielle T.; Webster, Jonathan; Ambinder, Alexander; Smith, B. Douglas; Levis, Mark J.; Varadhan, Ravi; Jones, Richard J.; Jain, Tania
Journal:
Leukemia & lymphoma
Issue:
Volume 63:Issue 8(2022)
Page Start:
1942
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search

  • MDS/MPN -- HMA -- genomics -- response -- survival 1